-The Hindu Despite limitations, the use of randomised control trials has led to a paradigm shift in development policy evaluation If Rip Van Winkle was an academic economist and woke up from a two-decade long sleep this week, he would be baffled by the news of the Nobel Prize in Economics this year awarded to Abhijit Banerjee, Esther Duflo, and Michael Kremer for pioneering the use of randomised control trials (RCTs) in...

-TheWire.in All three winners argue that using randomised control trials can lead to better public policy interventions. New Delhi: The 2019 Nobel Prize for economics has been awarded to three economists who have focused on framing policies by first measuring the outcomes of alternative interventions on randomly chosen samples from a target population. Abhijit Banerjee, Esther Duflo and Michael Kremer have all worked on using this method to argue that randomised control trials...

-Hindustan Times With little transparency on how such deaths are investigated, and new rules relaxing how clinical trials are conducted in India, this data could be a poor estimate, said experts. Mumbai: At least 1,100 people who took part in clinical trials over the past four years have died, and 88 of these deaths were caused by direct side effects of the trials, the health ministry told the Rajya Sabha last week. But,...

-Deccan Chronicle Ayush ministry states that experience and evidence of effectiveness of these drugs is based on textual rationale and published in literature. Hyderabad: Fraudsters would flourish if patented or proprietary Ayruvedic, Siddha and Unani products are given licence without insisting on safety trials, industry experts and medical professionals have stated. The Centre has issued drug regulators in states a directive to issue licenses to patented and proprietary products of Ayurvedic, Siddha and...

-Livemint.com WHO says the Indian govt should ‘reconsider’ the compensation clause because an approval to the rules in the current form would affect the conduct of clinical trials in India New Delhi: The World Health Organization (WHO) has told the central government that the United Nations (UN) agency’s work with India would be “hampered” and drug companies driven away if the government goes ahead with stringent draft rules for compensation in case...